Related Experiment Video
Updated: Jul 28, 2026

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer
1Department of Obstetrics and Gynecology, University of Toronto, Ontario, Canada.
Objective:
SPARC (secreted protein, acidic, rich in cysteine) is a calcium-binding counteradhesive glycoprotein that has the potential to play an important role in promoting tumor progression and invasiveness. SPARC has been reported to be markedly down-regulated in ovarian carcinomas relative to the normal surface epithelium and has been suggested to act as a tumor suppressor in ovarian cancer. To more precisely define potential changes in SPARC expression associated with malignant transformation of the ovary, we compared the distribution of SPARC mRNA and protein expression in patient specimens of malignant and nonmalignant ovaries.
Method:
SPARC mRNA and protein expression was examined in 24 human invasive ovarian cancers, 5 tumors of low malignant potential (LMP), and 8 nonmalignant ovaries by in situ hybridization and immunohistochemistry.
Results:
In nonmalignant ovaries, SPARC mRNA expression was restricted to thecal and granulosa cells of vessiculated follicles. Cytoplasmic SPARC immunoreactivity was observed in these compartments, whereas variable SPARC immunostaining was observed in normal surface epithelial cells. In contrast, high-level expression of SPARC mRNA and protein was detected in stroma of ovaries containing malignant tumor cells, particularly at the tumor-stromal interface of the invading tumors. Lower levels and a more diffuse pattern of SPARC mRNA expression were associated with LMP specimens. SPARC mRNA was not expressed by ovarian adenocarcinoma or by surface epithelial cells. Consistent with the in situ hybridization data, SPARC immunoreactivity was found throughout the reactive stroma of specimens containing ovarian carcinoma. However, despite the lack of detectable SPARC mRNA, SPARC immunoreactivity was consistently observed within the cytoplasm of cancer cells.
Conclusion:
The pattern of SPARC expression shown in this study indicates that SPARC is up-regulated in reactive stroma associated with invasive ovarian cancer. Moreover, these results raise the possibility that SPARC secreted from the stroma is internalized by ovarian cancer cells and may exert important intracellular effects upon these cells.
Insights
Secreted protein, acidic, rich in cysteine (SPARC) is upregulated in the stroma of invasive ovarian cancer. SPARC may be internalized by cancer cells, influencing their behavior.
Area of Science:
- Oncology
- Molecular Biology
- Gynecologic Pathology
Background:
- Secreted protein, acidic, rich in cysteine (SPARC) is a glycoprotein implicated in tumor progression.
- SPARC is typically downregulated in ovarian carcinomas, suggesting a tumor suppressor role.
- Understanding SPARC expression changes during ovarian malignant transformation is crucial.
Purpose of the Study:
- To investigate the distribution of SPARC mRNA and protein in malignant and nonmalignant ovarian tissues.
- To clarify the role of SPARC in ovarian cancer development and invasiveness.
Main Methods:
- In situ hybridization and immunohistochemistry were used to examine SPARC expression.
- Patient specimens included 24 invasive ovarian cancers, 5 tumors of low malignant potential (LMP), and 8 nonmalignant ovaries.
Main Results:
- SPARC mRNA and protein were detected in specific cells of nonmalignant ovaries.
- Invasive ovarian cancers showed high SPARC mRNA and protein expression in the tumor stroma, especially at the invasive front.
- SPARC protein was found in cancer cells, despite absent mRNA, suggesting internalization.
Conclusions:
- SPARC is upregulated in the reactive stroma of invasive ovarian cancer.
- Stromal SPARC may be internalized by ovarian cancer cells, potentially influencing intracellular functions.
Related Concept Videos
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

